MedPath

吉林敖东集团金海发药业股份有限公司

Ownership
-
Established
2004-10-27
Employees
-
Market Cap
-
Website
http://aodjhf.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

NMPA:49

Drug Approvals

根痛平丸

Approval Number
国药准字Z20090823
Approval Date
Apr 19, 2024
NMPA

前列回春片

Approval Number
国药准字Z20184076
Approval Date
Oct 19, 2023
NMPA

Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
复方氨酚烷胺片
Approval Number
国药准字H20184006
Approval Date
Feb 14, 2023
NMPA

更衣胶囊

Approval Number
国药准字Z20184002
Approval Date
Jan 9, 2023
NMPA

乳宁片

Approval Number
国药准字Z20184004
Approval Date
Jan 9, 2023
NMPA

抗饥消渴片

Approval Number
国药准字Z20184003
Approval Date
Jan 9, 2023
NMPA

复方丹参片

Approval Number
国药准字Z20184001
Approval Date
Jan 9, 2023
NMPA

益母草颗粒

Approval Number
国药准字Z20174035
Approval Date
Sep 7, 2022
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H20174074
Approval Date
Sep 6, 2022
NMPA

复方金银花颗粒

Approval Number
国药准字Z20174033
Approval Date
Sep 5, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.